Skip to main content
. Author manuscript; available in PMC: 2022 Nov 15.
Published in final edited form as: Alzheimers Dement. 2021 Nov 10;17(11):1855–1867. doi: 10.1002/alz.12491

FIGURE 2.

FIGURE 2

ATN biomarker profile of aMCI participants in different classification groups. Classification model is developed by applying RUSBoost ML models (top) or logistic regression (LR) models (bottom) to demographics, APOE ε4 status, and neuropsychological tests. Numbers represent the percentage in a particular color. A, amyloid; aMCI, amnestic mild cognitive impairment; APOE, apolipoprotein E; CN, cognitively normal; FDG, 18F-fluorodeoxyglucose; ML, machine learning; N, neurodegeneration; SUVR, standardized uptake value ratio; T, tau